Brief: Xspray Receives FDA Clearance Of IND For HyNap-Dasa

Xspray Pharma publ AB

31/10/2019 11:05

Oct 31 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * XSPRAY RECEIVES FDA CLEARANCE OF IND FOR HYNAP-DASA
    * APPLICATION HAS NOW BEEN GIVEN CLEARANCE BY FDA'S DIVISION
OF
HEMATOLOGY PRODUCTS
    * ANNOUNCES THAT US FOOD AND DRUG ADMINISTRATION (FDA) HAS
CLEARED
COMPANY'S IND APPLICATION FOR PRODUCT CANDIDATE HYNAP-DASA

Source text for Eikon:  ID:nWkr76b5Jp 
Further company coverage:  XSPRAY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))